Showing 301 - 320 results of 2,530 for search '"vaccine"', query time: 0.09s Refine Results
  1. 301
  2. 302
  3. 303

    Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection by Nicole Le Saux, Julie A Bettinger, Susan Wootton, Scott A Halperin, Wendy Vaudry, David W Scheifele, Raymond Tsang

    Published 2009-01-01
    “…The availability of a quadrivalent conjugate vaccine against serogroups A, C, Y and W135 focuses attention on serogroup Y disease as it becomes relatively more prominent as a cause of vaccine-preventable invasive meningococcal disease. …”
    Get full text
    Article
  4. 304

    Acceptability of COVID-19 Vaccination among Health Care Workers in Ghana by Martin Wiredu Agyekum, Grace Frempong Afrifa-Anane, Frank Kyei-Arthur, Bright Addo

    Published 2021-01-01
    “…Because health care workers are a reliable source of health information, their acceptance or rejection of COVID-19 vaccines can influence the general population's uptake of COVID-19 vaccines. …”
    Get full text
    Article
  5. 305

    COVID-19 Vaccination Associated Bilateral Pulmonary Embolism: Cause or Coincidence by John Omotola Ogunkoya, Marion Itohan Ogunmola, Akinwale Folarin Ogunlade, Akindele Emmanuel Ladele

    Published 2022-01-01
    “…The patient had the booster dose of moderna (mRNA) COVID-19 vaccine a month before the onset of symptoms. There was associated anorexia, generalized body pain, joint pain, and weakness. …”
    Get full text
    Article
  6. 306
  7. 307
  8. 308
  9. 309

    The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia by Colleen Burgess, Stephanie Kujawski, Ajda Lapornik, Goran Bencina, Manjiri Pawaskar

    Published 2022-09-01
    “…**Background:** Despite the substantial burden of varicella infection, Slovenia does not currently have a universal varicella vaccination (UVV) program. We modeled the long-term clinical and economic impact of implementing 2-dose UVV strategies compared with no vaccination in Slovenia. …”
    Get full text
    Article
  10. 310
  11. 311

    Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals by Pit Sze Liew, Mohd Hair-Bejo

    Published 2015-01-01
    “…Although there are no edible plant-produced animal vaccines in the market, plant-based vaccine technology has great potentials. …”
    Get full text
    Article
  12. 312
  13. 313

    Fractional-Order Model for Evolution of Bovine Tuberculosis with Vaccination and Contaminated Environment by Boubacar Diallo, Jeconia Abonyo Okelo, Shaibu Osman, Simon Karanja, Nnaemeka Stanley Aguegboh

    Published 2024-01-01
    “…We use a fractional-order model with the Caputo sense to examine the evolution of bovine tuberculosis transmission in human and animal populations, including a vaccine compartment for humans. We derived and obtained the threshold quantity R0 to ascertain the illness state. …”
    Get full text
    Article
  14. 314
  15. 315
  16. 316

    The Effect of Pulse Vaccination and Treatment on SIR Epidemic Model with Media Impact by Zhi-Long He, Lin-Fei Nie

    Published 2015-01-01
    “…We propose a novel SIR epidemic dynamical control model with media impact, where the state dependent pulse vaccination and medication treatment control strategies are being introduced to prevent the spread of disease at different control threshold values. …”
    Get full text
    Article
  17. 317

    Whole-cell vaccine of Streptococcus agalactiae in Oreochromis sp. with immersion method by , Sukenda, Trian Rizky Febriansyah, Sri Nuryati

    Published 2015-05-01
    “…Fish was vaccinated through bath immersion at a concentration of 109 cfu/mL. …”
    Get full text
    Article
  18. 318

    Neutralizing antibody responses to three XBB protein vaccines in older adults by Guo-Jian Yang, Mei Lu, Rui-Rui Chen, Shuang-Qing Wang, Sheng Wan, Xue-Dong Song, Guo-Ping Cao, Lei Lv, Xue-Juan He, Bing-Dong Zhan, Mai-Juan Ma

    Published 2025-02-01
    “…The results showed that all three XBB-containing vaccines substantially enhanced the neutralizing antibody response, with 100% of vaccinees having detectable antibody titers against ancestral D614G and variants BA.5, XBB.1.5, JN.1, KP.2, and KP.3 after booster immunization. …”
    Get full text
    Article
  19. 319
  20. 320

    Effectiveness and Cost-Benefit of an Influenza Vaccination Program for Health Care Workers by Annalee Yassi, Joel Kettner, Greg Hammond, Mary Cheang, Myrna McGill

    Published 1991-01-01
    “…Sensitivity analyses highlighted vaccine efficacy and absenteeism due to influenza and adverse reactions to vaccination as the most important factors; with time lost due to adverse reactions as much as 0.013 days per vaccinated employee and a vaccine efficacy of 70%, net positive benefits could be achieved if influenza-induced absenteeism is 0.5% or greater of paid employee time during the epidemic season. …”
    Get full text
    Article